Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12

International Journal of Immunopharmacology

Volumn 22, Issue 1, 2000, Pages 35-43

  Singh, Sukh Mahendra ^a   Yanagawa, Hiroaki ^a   Hanibuchi, Masaki ^a   Miki, Toyokazu ^a   Okamura, Haruki ^b   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Interleukin 12; Interleukin 18; Lung cancer; Mononuclear cell; Tumor cytotoxicity

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVITY; CYTOTOXICITY; DAUDI CELL; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; KILLER CELL; LUNG CANCER; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TARGET CELL;

CYTOTOXICITY, IMMUNOLOGIC; DRUG SYNERGISM; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-18; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033956722     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00062-4     Document Type: Article

References (34)

1. Nakamura K., Okamura H., Wada M., Nagata K., Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun. 57:1989;590-595.
2. Dinarello C.A., Novick D., Puren A.J., Fantuzii G., Shapiro L., Muhl H., Yoon D.Y., Rexnikov L.L., Kim S.H., Rubinstein M. Overview of interleukin-18: more than an interferon-gamma. J. Leukoc. Biol. 63:1998;658-664.
3. Gillespie M.T., Horwood N.J. Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev. 9:1998;109-116.
4. Coughlin C.M., Salhany K.E., Wysocka M., Aruga E., Kurzawa H., Chang A.E., Hunter C.A., Fox J.C., Trinchieri G., Lee W.M.F. Interleukin-12 and interleukin-18 synergistically induced murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101:1998;1441-1452.
5. Fukumoto H., Nishio M., Nishio K., Heike Y., Arioka H., Kurokawa H., Ishida T., Fukuoka K., Nomoto T., Ohe Y., Saijo N. Interferon-gramma-inducing factor gene transfection into Lewis lung carcinoma cells reduces tumorigenicity in vivo. Jpn J. Cancer Res. 88:1997;501-505.
6. Ohtsuki T., Micallef M.J., Tanimoto T., Ikeda M., Kurimoto M. Interleukin-18 enhances Fas Ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res. 17:1997;3253-3258.
7. Munder M., Mallo M., Eichmann K., Modolell M. Murine macrophages secrete interferon-gamma upon combined stimulation with interleukin-12 and interleukin-18: A novel pathway of autocrine macrophage activation. J. Exp. Med. 187:1998;2103-2108.
8. Tan J., Crucian B.E., Chang A.E., Aruga E., Aruga A., Dovhey S.E., Tanigawa K., Yu H. Interferon-gamma-inducing factor elicits antitumor immunity in association with interferon-gamma production. J. Immunother. 21:1998;48-55.
9. Micallef M.J., Yoshida K., Kawai S., Hanaya T., Kohno K., Arai S., Tanimoto T., Torigoe K., Fujii M., Ikeda M., Kurimoto M. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol. Immunother. 43:1997;361-367.
10. Osaki T., Peron J.M., Cai Q., Okamura H., Robbins P.D., Kurimoto M., Lotze M.T., Tahara H. Interferon-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J. Immunol. 160:1998;1742-1749.
11. Dao T., Mehal W.Z., Crispe I.N. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol. 161:1998;2217-2222.
12. Ushio S., Motoshi N., Okura T., Kazuko H., Nukada Y., Akita K., Tanabe F., Konishi K., Micallef M., Fujii M., Torigoe K., Tanimoto T., Fukuda S., Ikeda M., Okamura H., Kurimoto M. Cloning of the cDNA for human interferon-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156:1996;4274-4279.
13. Kohyama M., Saijyo K., Hayasida M., Yasugi T., Kurimoto M., Ohno T. Direct activation of human CD8+ cytotoxic T lymphocytes by IL-18. Jpn J. Cancer Res. 89:1998;1041-1048.
14. Paesmans M., Sculier J.P., Libert P., Bureau G., Dabouis G., Thiriaux J., Michel J., Van Cutsem O., Sergysel S., Mommen P., Klastersky J. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1052 patients. J. Clin. Oncol. 13:1995;1221-1230.
15. Nii A., Sone S., Utsugi T., Yanagawa H., Ogura T. Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state. Int. J. Cancer. 41:1988;33-40.
16. Sone S., Kunishige E., Fawzy F., Yanagawa H., Nii A., Maeda K., Atagi S., Heike Y., Nishioka Y., Mizuno K., Ogura T. Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients. Jpn J. Cancer Res. 82:1991;716-723.
17. Haku T., Yanagawa H., Nabioullin R., Takeuchi E., Sone S. Interleukin-12-mediated killer activity in lung cancer patients. Cytokine. 9:1997;846-852.
18. Hiramatsu K., Yanagawa H., Haku T., Sone S. Generation of killer activity by IL-12 of mononuclear cells in malignant pleural effusions due to lung cancer. Cancer Immunol. Immunother. 46:1998;1-6.
19. Takeuchi E., Yanagawa H., Yano S., Haku T., Sone S. Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanism. Jpn J. Cancer Res. 87:1996;1251-1258.
20. Takeuchi E., Yanagawa H., Suzuki Y., Bando H., Sone S. Comparative analysis of interleukin-15 and interleukin-2 for induction of killer activity and of type 2 cytokine production by mononuclear cells from lung cancer patients. Br. J. Cancer. 78:1998;616-620.
21. Takeda K., Tasutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T., Okamura H., Nakanishi K., Akira S. Defective NK cell activity and Th1 responses in IL-18-deficient mice. Immunity. 8:1998;383-389.
22. Yoshimoto T., Takeda K., Tanaka T., Ohkusu K., Kashiwamura S., Okamura H., Arira S., Nakanishi K. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for interferon gamma production. J. Immunol. 161:1998;3400-3407.
23. Tomura M., Zhou X.Y., Maruo S., Ahn H.J., Hamaoka T., Okamura H., Nakanishi K., Tanimoto T., Kurimoto M., Fujiwara H. A critical role for IL-18 in the proliferation and activation of NK1.1+CD3-cells. J. Immunol. 160:1998;4738-4746.
24. Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., Kurimoto M. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature. 78:1995;88-92.
25. Onda H., Asano T., Sugino H., Kakimura A. Purification and characterization of recombinant human interleukin-2 produced in Escherichia coli. Biochem. Biophys. Res. Commun. 130:1985;692-699.
26. Veoka H., Kiura K., Moritaka T., Shibayama T., Tabata M., Segawa Y., Takigawa N. Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens. Acta Med. Okayama. 47:1993;233-241.
27. Sone S., Utsugi T., Nii A., Ogura T. Effects of human alveolar macrophages on the induction of lymphokine (IL-2) activated killer cells. J. Immunol. 139:1987;29-34.
28. Yanagawa H., Yano S., Haku T., Ohmoto Y., Sone S. Interleukin-1 receptor antagonist in pleural effusion due to inflammatory and malignant lung disease. Eur. Respir. J. 9:1996;1211-1216.
29. Zhang T.T., Kawakami K., Qureshi M.H., Okamura H., Kurimoto M., Saito A. Interleukin-12 and interleukin 18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of interferon by natural killer cells. Infect Immun. 65:1997;3594-3599.
30. Hyodo Y., Matsui K., Hayashi N., Tsutsui H., Kashiwamura S., Yamauchi H., Hiroishi K., Takeda K., Tagawa Y., Iwakura Y., Kayagaki N., Kurimoto M., Okamura H., Hada T., Yagita H., Akira S., Nakanishi K., Higashino K. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. 162:1999;1662-1668.
31. Fehniger T.A., Shah M.H., Turner M.J., van Deusen J.B., Whitman S.P., Cooper M.A., Suzuki K., Wechser M., Goodsaid F., Caligiuri M.A. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 and IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162:1999;4511-4520.
32. Lucey D.R., Clerici M., Shearer G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9:1996;532-562.
33. Pai K., Yanagawa H., Takeuchi E., Suzuki Y., Hanibuchi M., Parajuri P., Sone S. Differential effect of interleukin 10 on interleukin 12- and interleukin 2-mediated killer induction from blood mononuclear cells. Oncol. Res. 10:1998;295-300.
34. Micallef M.J., Tanimoto T., Torigoe K., Nishida Y., Kohno K., Ikegami H., Kurimoto M. Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity. Cancer Immunol. Immunother. 48:1999;109-117.